Latest filing published 02 Jun 2017 for OptimizeRx Corp, €348k.
Insider track record
No signal scores available.
David Harrell: trading record in brief
All filings by David Harrell on record concern OptimizeRx Corp. The record holds 9 filings, for trades running from 19 April 2010 to 1 June 2017.
The open-market record consists of 2 sales worth €1.0M, with no purchase. Besides market trades, the filings include 3 share grants.
The latest filing, published on 2 June 2017, reports a transaction of €348k in OptimizeRx Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 5 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to David Harrell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 500,000 shares@ US$0.78100.0% of flowCommon StockSEC:0001213900-17-006118:0
- 79,042 shares0Common StockSEC:0001213900-15-004801:0
- 60,938 shares0Common StockSEC:0001255294-14-000554:0
- 100,000 shares0Common StockSEC:0001255294-14-000554:1
- 552,500 shares@ US$1.60Common StockSEC:0001255294-14-000370:0
- 400,000 shares@ US$1.25Common StockSEC:0001255294-10-000827:0
- 300,000 shares0Common StockSEC:0001255294-10-000803:0
- 300,000 shares0Common StockSEC:0001255294-10-000325:0
- 24,000 shares0Common StockSEC:0001255294-10-000311:0
9 of 9 declarations
